Targeting KRASp.G12C Mutation in Advanced Non-Small Cell Lung Cancer: a New Era Has Begun.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 12, p. 1699, doi. 10.1007/s11864-022-01033-4
- By:
- Publication type:
- Article
Works matching IS 15272729 AND DT 2022 AND VI 23 AND IP 12
Results: 16
1
2
Correction to: Approach to Stereotactic Body Radiotherapy for the Treatment of Advanced Hepatocellular Carcinoma in Patients with Child-Pugh B-7 Cirrhosis.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
3
Combinations of Chemotherapy and PD-1/PD-L1 Inhibitors in Sarcoma.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 12, p. 1861, doi. 10.1007/s11864-022-01036-1
- By:
- Publication type:
- Article
4
Evaluating the Patient with Neurotoxicity after Chimeric Antigen Receptor T-cell Therapy.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 12, p. 1845, doi. 10.1007/s11864-022-01035-2
- By:
- Publication type:
- Article
5
Adjuvant Immunotherapy in Patients with Early-Stage Non-small Cell Lung Cancer and Future Directions.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 12, p. 1721, doi. 10.1007/s11864-022-01034-3
- By:
- Publication type:
- Article
6
Correction to: BRAF Inhibitor Resistance in Meslanoma: Mechanisms and Alternative Therapeutic Strategies.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
7
Central Nervous System Prophylaxis and Treatment in Acute Leukemias.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 12, p. 1829, doi. 10.1007/s11864-022-01032-5
- By:
- Publication type:
- Article
8
Contemporary Use of Hormonal Therapy in Endometrial Cancer: a Literature Review.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 12, p. 1818, doi. 10.1007/s11864-022-01031-6
- By:
- Publication type:
- Article
9
Targeted Therapies in the Treatment of Uterine Serous Carcinoma.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 12, p. 1804, doi. 10.1007/s11864-022-01030-7
- By:
- Publication type:
- Article
10
Optimal First-Line Therapy for Metastatic Adenocarcinoma of the Esophagus.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 12, p. 1748, doi. 10.1007/s11864-022-01029-0
- By:
- Publication type:
- Article
11
Understanding Cancer Cachexia and Its Implications in Upper Gastrointestinal Cancers.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 12, p. 1732, doi. 10.1007/s11864-022-01028-1
- By:
- Publication type:
- Article
12
Cancer Immunotherapy: Fecal Microbiota Transplantation Brings Light.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 12, p. 1777, doi. 10.1007/s11864-022-01027-2
- By:
- Publication type:
- Article
13
Surgical Principles in the Management of Lung Neuroendocrine Tumors: Open Questions and Controversial Technical Issues.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 12, p. 1645, doi. 10.1007/s11864-022-01026-3
- By:
- Publication type:
- Article
14
Approach to Stereotactic Body Radiotherapy for the Treatment of Advanced Hepatocellular Carcinoma in Patients with Child-Pugh B-7 Cirrhosis.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 12, p. 1761, doi. 10.1007/s11864-022-01025-4
- By:
- Publication type:
- Article
15
Current Practice in Carcinoid Heart Disease and Burgeoning Opportunities.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 12, p. 1793, doi. 10.1007/s11864-022-01023-6
- By:
- Publication type:
- Article
16
Management and Treatment of Non-small Cell Lung Cancer with MET Alteration and Mechanisms of Resistance.
- Published in:
- Current Treatment Options in Oncology, 2022, v. 23, n. 12, p. 1664, doi. 10.1007/s11864-022-01019-2
- By:
- Publication type:
- Article